Evidence map›Paper›PMID 36305026›Full record

ArticlePathologica2022

DOG-1 positive primary acinic cell carcinoma of the lung and investigation of molecular status.

Lorenzo Nibid, Luca Frasca, Giovanna Sabarese, Daniela Righi, Silvia Taccogna, Pierfilippo Crucitti, Paolo Graziano, Giuseppe Perrone

Abstract readCase Reports
In one paragraph

Article in Pathologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lorenzo NibidPathology Unit, Campus Bio-Medico University Hospital Foundation, Rome, Italy.
Luca FrascaThoracic Surgery Unit, Campus Bio-Medico University Hospital Foundation, Rome, Italy.
Giovanna SabaresePathology Unit, Campus Bio-Medico University Hospital Foundation, Rome, Italy.
Daniela RighiPathology Unit, Campus Bio-Medico University Hospital Foundation, Rome, Italy.
Silvia TaccognaPathology Unit, Regina Apostolorum Hospital, Albano Laziale (RM), Italy.
Pierfilippo CrucittiThoracic Surgery Unit, Campus Bio-Medico University Hospital Foundation, Rome, Italy.
Paolo GrazianoPathology Unit, IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy.
Giuseppe PerronePathology Unit, Campus Bio-Medico University Hospital Foundation, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary acinic cell carcinoma (ACC) of the lung is an extremely rare neoplasm that more often arises near to a right bronchus. It is characterized by two populations of clear and dark eosinophilic cells, arranged in a glandular acinar pattern. Mitosis are rare and tumor cells show small and eccentric nuclei. Positive stain for PAS, PAS-D, cytokeratin, A1AT and A1ACT is reported, while TTF1, p40, synaptophysin, SMA, and S100 are substantially negative. DOG-1 positive stain was observed in ACC of the salivary glands and its negativity was proposed to distinguish between primary and metastatic ACC of the lung. Here, we report the 30th case of primary ACC of the lung, describing the immunohistochemical positivity for DOG-1 and the molecular status of the neoplasm for the first time.

Indexed as

Carcinoma, Acinar CellSalivary Gland NeoplasmsHumansLungacinic cell carcinomaDOG-1lung cancerNR4A3salivary gland-type tumor

Identifiers

PMID36305026
PMCPMC9614299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.